D'Elia HF - Search Results

1

Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis.

D'Elia HF, Larsen A, Mattsson LA, Waltbrand E, Kvist G, Mellström D, Saxne T, Ohlsson C, Nordborg E, Carlsten H. D'Elia HF, et al. J Rheumatol. 2003 Jul;30(7):1456-63. J Rheumatol. 2003. PMID: 12858441 Clinical Trial.

2

The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis.

d'Elia HF, Carlsten H. d'Elia HF, et al. Scand J Immunol. 2008 Dec;68(6):661-7. doi: 10.1111/j.1365-3083.2008.02186.x. Scand J Immunol. 2008. PMID: 19086108 Free article. Clinical Trial.

3

Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1.

D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H. D'Elia HF, et al. Arthritis Res Ther. 2003;5(4):R202-9. doi: 10.1186/ar761. Epub 2003 May 1. Arthritis Res Ther. 2003. PMID: 12823855 Free PMC article. Clinical Trial.

4

The decrease of soluble RAGE levels in rheumatoid arthritis patients following hormone replacement therapy is associated with increased bone mineral density and diminished bone/cartilage turnover: a randomized controlled trial.

Pullerits R, d'Elia HF, Tarkowski A, Carlsten H. Pullerits R, et al. Among authors: d elia hf. Rheumatology (Oxford). 2009 Jul;48(7):785-90. doi: 10.1093/rheumatology/kep079. Epub 2009 May 4. Rheumatology (Oxford). 2009. PMID: 19416946 Clinical Trial.

5

Fatigue and blood pressure in primary Sjogren's syndrome.

d'Elia HF, Rehnberg E, Kvist G, Ericsson A, Konttinen Y, Mannerkorpi K. d'Elia HF, et al. Scand J Rheumatol. 2008 Jul-Aug;37(4):284-92. doi: 10.1080/03009740801907995. Scand J Rheumatol. 2008. PMID: 18612929

6

Salivary resistin reflects local inflammation in Sjögren's syndrome.

Boström EA, d'Elia HF, Dahlgren U, Simark-Mattsson C, Hasséus B, Carlsten H, Tarkowski A, Bokarewa M. Boström EA, et al. Among authors: d elia hf. J Rheumatol. 2008 Oct;35(10):2005-11. Epub 2008 Aug 15. J Rheumatol. 2008. PMID: 18709689 Clinical Trial.

7

Role of resistin as a marker of inflammation in systemic lupus erythematosus.

Almehed K, d'Elia HF, Bokarewa M, Carlsten H. Almehed K, et al. Among authors: d elia hf. Arthritis Res Ther. 2008;10(1):R15. doi: 10.1186/ar2366. Epub 2008 Jan 30. Arthritis Res Ther. 2008. PMID: 18234104 Free PMC article.

8

Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sjogren syndrome: an explanatory interventional study.

d'Elia HF, Bjurman C, Rehnberg E, Kvist G, Konttinen YT. d'Elia HF, et al. Ann Rheum Dis. 2009 Feb;68(2):285-6. doi: 10.1136/ard.2008.091256. Ann Rheum Dis. 2009. PMID: 19139206 Clinical Trial. No abstract available.

9

Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register.

Frisell T, Dehlin M, Di Giuseppe D, Feltelius N, Turesson C, Askling J; ARTIS Study Group. Frisell T, et al. Rheumatology (Oxford). 2019 Jan 21. doi: 10.1093/rheumatology/key433. Online ahead of print. Rheumatology (Oxford). 2019. PMID: 30668875

10

[Cardiovascular risk in inflammatory systemic disease should be assessed regularly. The Swedish Society of Rheumatology has formulated guidelines for primary prevention].

Jonsson SW, Ljung L, D'Elia HF, Henrohn D, Turesson C, Svenungsson E. Jonsson SW, et al. Among authors: d elia hf. Lakartidningen. 2012 Jan 11-17;109(1-2):27-9. Lakartidningen. 2012. PMID: 22468407 Swedish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters